Herpes Zoster Vaccination (Shingles)
In this page
Subscribe to our Newsletter
Herpes Zoster (Shingles) Vaccination
- A single lifetime dose
- Recommended for individuals over the age of 60 but can be given to those between the ages of 50-59
- Vaccination results in a 50% reduction in herpes zoster (perhaps 40% in RA patients)
- Vaccination results in a 66% reduction in post-herpetic neuralgia
- Where possible give 4 weeks prior to the initiation of biologic therapy
- Most would give this vaccine to patients receiving low dose prednisone (<20 mg/day).
- There is less data but it may be given to patients on low dose immunosuppression such as low dose methotrexate (<0.4 mg/kg/week) or azathioprine (<3 mg/kg/day)
- The effectiveness of this vaccine in patients who have had shingles is not known. Should be given 1 year after last shingles outbreak.